The Current Ratio as of December 2025 (TTM) for Lexeo Therapeutics, Inc. Common Stock (LXEO) is 4.43

According to Lexeo Therapeutics, Inc. Common Stock’s latest financial reports and current stock price. The company's current Current Ratio is 4.43. This represents a change of -8.19% compared to the average of 4.83 of the last 4 quarters.

Lexeo Therapeutics, Inc. Common Stock (LXEO) Historical Current Ratio (quarterly & annually)

How has LXEO Current Ratio performed in the past?

The mean historical Current Ratio of Lexeo Therapeutics, Inc. Common Stock over the last ten years is 15.76. The current 4.43 Current Ratio has changed 2.71% with respect to the historical average. Over the past ten years (40 quarters), LXEO's Current Ratio was at its highest in in the June 2024 quarter at 9.38. The Current Ratio was at its lowest in in the March 2022 quarter at 0.

Lexeo Therapeutics, Inc. Common Stock (LXEO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Lexeo Therapeutics, Inc. Common Stock Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lexeo Therapeutics, Inc. Common Stock (LXEO) Average Current Ratio

How has LXEO Current Ratio performed in the past?

The current Current Ratio of Lexeo Therapeutics, Inc. Common Stock (LXEO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Lexeo Therapeutics, Inc. Common Stock (LXEO) Current Ratio vs. Peers

How is LXEO’s Current Ratio compared to its peers?

Lexeo Therapeutics, Inc. Common Stock’s Current Ratio is less than Kyverna Therapeutics, Inc. (5.39), less than Contineum Therapeutics, Inc. Class A Common Stock (29.07), less than Silence Therapeutics plc (7.69), less than Larimar Therapeutics, Inc. (5.46), greater than Capricor Therapeutics, Inc. (4.37), less than Mereo BioPharma Group plc (8.13), less than Voyager Therapeutics, Inc. (6.19), greater than DBV Technologies S.A. (2.45), greater than Amarin Corporation plc (3.45), greater than Vanda Pharmaceuticals Inc. (3.12),

Build a custom stock screener for Lexeo Therapeutics, Inc. Common Stock (LXEO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lexeo Therapeutics, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lexeo Therapeutics, Inc. Common Stock (LXEO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lexeo Therapeutics, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.